Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
409.47
-6.78 (-1.63%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,357,941
Open
415.61
Bid (Size)
408.00 (40)
Ask (Size)
411.00 (80)
Prev. Close
416.25
Today's Range
406.67 - 416.27
52wk Range
362.50 - 519.88
Shares Outstanding
259,428,394
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
November 07, 2025
The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results...
Via
MarketMinute
Topics
Artificial Intelligence
Intellectual Property
Global Markets Brace for Inflation's Enduring Grip: A November 2025 Outlook
November 07, 2025
As November 2025 unfolds, global financial markets find themselves in a complex and challenging environment, bracing for the enduring grip of inflation. Despite some signs of moderating headline...
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Performance
YTD
+0.9%
+0.9%
1 Month
-2.8%
-2.8%
3 Month
+11.7%
+11.7%
6 Month
-3.7%
-3.7%
1 Year
-18.5%
-18.5%
More News
Read More
Earnings Scheduled For November 3, 2025
November 03, 2025
Via
Benzinga
FDA Fast-Tracks 6 More Drugs - Obesity And Cancer Drugs Included
November 07, 2025
Via
Benzinga
2 Nasdaq 100 Stocks with Competitive Advantages and 1 Facing Challenges
November 05, 2025
Via
StockStory
VRTX Q3 Deep Dive: New Product Launches and Pipeline Progress Shape Outlook
November 04, 2025
Via
StockStory
Vertex Pharmaceuticals (NASDAQ:VRTX) Reports Q3 In Line With Expectations
November 03, 2025
Via
StockStory
Palantir Weighs On Wall Street, Bitcoin Slumps 5%: What's Moving Markets Tuesday?
November 04, 2025
Via
Benzinga
Vertex Pharma Dips Despite Quarterly Beat And Slight Guidance Book
November 03, 2025
Via
Investor's Business Daily
Vertex Reports Third Quarter 2025 Financial Results
November 03, 2025
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex Pharmaceuticals Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
November 03, 2025
Via
Benzinga
2 Healthcare Stocks for Individual Investors With a 20-Year Time Horizon
November 03, 2025
Via
The Motley Fool
Topics
Intellectual Property
Inflation-Proof Investing: Which Growth Stock Will Double Your Money in 6 Years?
November 03, 2025
Via
The Motley Fool
Topics
Economy
Government
World Trade
Nvidia, Amazon Extend Rally, Bitcoin Sinks To $107,000: What's Moving Markets Monday?
November 03, 2025
Via
Benzinga
My Top Growth Stock to Buy in November
November 02, 2025
Via
The Motley Fool
Vertex Pharmaceuticals (VRTX) Q3 Earnings: What To Expect
November 01, 2025
Via
StockStory
How Royalty Pharma Prints Cash Without Biotech's Biggest Risks
October 31, 2025
Via
MarketBeat
Here's How Much $100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today
October 30, 2025
Via
Benzinga
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Fundamentals and Bullish Technical Setup
October 29, 2025
Via
Chartmill
If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These
October 28, 2025
Via
The Motley Fool
Vertex to Participate in the UBS Global Healthcare Conference on November 11
October 27, 2025
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030
October 27, 2025
Via
The Motley Fool
Topics
Intellectual Property
The Best Stocks to Invest $50,000 In Right Now
October 24, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Energy
Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference
October 23, 2025
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A Value Investment Case Study
October 20, 2025
Via
Chartmill
Frequently Asked Questions
Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 409.47
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 11/07/25 04:00 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 106.23B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 106B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.